Mp43-01 Efficacy and Safety of Analgesic-Eluting Urethral Catheter After Urologic Surgery: A Pilot Prospective Study

You have accessJournal of UrologySurgical Technology & Simulation: Instrumentation & Technology II (MP43)1 May 2024MP43-01 EFFICACY AND SAFETY OF ANALGESIC-ELUTING URETHRAL CATHETER AFTER UROLOGIC SURGERY: A PILOT PROSPECTIVE STUDY Hwanik Kim, Kookjin Huh, Young Jun Uhm, Il Tae Son, Dae-Kyung Kwak, Yi-Hwa Choi, Kyung Jin Chung, Sang Hoon Song, and Myungsun Shim Hwanik KimHwanik Kim , Kookjin HuhKookjin Huh , Young Jun UhmYoung Jun Uhm , Il Tae SonIl Tae Son , Dae-Kyung KwakDae-Kyung Kwak , Yi-Hwa ChoiYi-Hwa Choi , Kyung Jin ChungKyung Jin Chung , Sang Hoon SongSang Hoon Song , and Myungsun ShimMyungsun Shim View All Author Informationhttps://doi.org/10.1097/01.JU.0001008720.96896.83.01AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Catheter-related bladder discomfort (CRBD) has been observed in many patients undergoing urethral catheterization. CRBD may be so severe that the patients require additional analgesics. This study evaluated the effects of analgesic-eluting urethral catheters on postoperative CRBD. METHODS: 30 patients undergoing urologic surgery requiring urinary catheterization were prospectively randomized to one of three groups (control arm, 0.5% ropivacaine 1 mL/hr arm [Study 1 arm], and 0.5% ropivacaine 2 mL/hr arm [Study 2 arm]; n=10 each). The incidence and severity of CRBD were assessed at 24 hours postoperatively as primary outcomes. The incidence of adverse events during Foley catheter use was also compared as a secondary outcome. RESULTS: The incidence of CRBD at 24 hours post-operatively in the control, study 1 and study 2 arms was 50.0%, 0%, and 0% respectively (p=0.002). The severity of CRBD at 24 hours post-operatively showed that subjects in study 1 and study 2 arms had significantly less post-operative CRBD than those in the control arm (visual analog score[VAS]; mean VAS of control, study 1, and study 2 arm : 2.1 vs 1.6 vs 0.9, p=0.045). Catheter-related urethral pain was considerably less severe in the study arms than in the control arm (VAS score: 6.2 vs. 1.5 vs. 1.4, p<0.001). The incidence and severity of postoperative catheter-related adverse events were not significantly different between groups (p=0.287). Peri-catheter leakage was more frequent in the study 2 arm compared to the other arms (p=0.057). CONCLUSIONS: An appropriate dose of ropivacaine eluting urethral catheter could not only alleviate catheter-related urethral pain but also reduce the incidence or severity of CRBD in patients undergoing urologic surgery without significant adverse events. Download PPT Source of Funding: None © 2024 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 211Issue 5SMay 2024Page: e692 Advertisement Copyright & Permissions© 2024 by American Urological Association Education and Research, Inc.Metrics Author Information Hwanik Kim More articles by this author Kookjin Huh More articles by this author Young Jun Uhm More articles by this author Il Tae Son More articles by this author Dae-Kyung Kwak More articles by this author Yi-Hwa Choi More articles by this author Kyung Jin Chung More articles by this author Sang Hoon Song More articles by this author Myungsun Shim More articles by this author Expand All Advertisement PDF downloadLoading ...